PASQUALETTI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.966
NA - Nord America 1.486
EU - Europa 1.051
SA - Sud America 779
AF - Africa 727
OC - Oceania 80
Continente sconosciuto - Info sul continente non disponibili 32
Totale 6.121
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.119
SG - Singapore 587
BR - Brasile 484
HK - Hong Kong 275
VN - Vietnam 230
CN - Cina 183
IT - Italia 113
PL - Polonia 77
NL - Olanda 76
RU - Federazione Russa 52
AR - Argentina 50
AT - Austria 45
DE - Germania 45
CO - Colombia 41
FI - Finlandia 38
EC - Ecuador 36
ZA - Sudafrica 35
ID - Indonesia 32
KR - Corea 32
MX - Messico 31
PE - Perù 31
ES - Italia 30
IQ - Iraq 30
PY - Paraguay 30
BA - Bosnia-Erzegovina 29
PK - Pakistan 29
FR - Francia 27
IN - India 27
SE - Svezia 27
AO - Angola 26
NI - Nicaragua 26
NO - Norvegia 26
UG - Uganda 26
ZM - Zambia 26
TR - Turchia 25
CL - Cile 24
PT - Portogallo 24
SA - Arabia Saudita 24
TZ - Tanzania 24
UA - Ucraina 24
UY - Uruguay 24
AE - Emirati Arabi Uniti 23
BJ - Benin 23
GM - Gambi 23
MY - Malesia 23
PA - Panama 23
TN - Tunisia 23
VE - Venezuela 23
AU - Australia 22
BD - Bangladesh 22
BY - Bielorussia 22
CA - Canada 22
CD - Congo 22
DO - Repubblica Dominicana 22
DZ - Algeria 22
JP - Giappone 22
MK - Macedonia 22
PS - Palestinian Territory 22
AZ - Azerbaigian 21
CG - Congo 21
CW - ???statistics.table.value.countryCode.CW??? 21
GF - Guiana Francese 21
IR - Iran 21
LB - Libano 21
NE - Niger 21
AL - Albania 20
CR - Costa Rica 20
GB - Regno Unito 20
KZ - Kazakistan 20
SK - Slovacchia (Repubblica Slovacca) 20
AM - Armenia 19
CI - Costa d'Avorio 19
CM - Camerun 19
EE - Estonia 19
ET - Etiopia 19
GR - Grecia 19
IS - Islanda 19
KG - Kirghizistan 19
LU - Lussemburgo 19
MA - Marocco 19
PH - Filippine 19
RS - Serbia 19
SI - Slovenia 19
TH - Thailandia 19
UZ - Uzbekistan 19
AF - Afghanistan, Repubblica islamica di 18
BB - Barbados 18
CV - Capo Verde 18
CZ - Repubblica Ceca 18
GA - Gabon 18
GT - Guatemala 18
HT - Haiti 18
HU - Ungheria 18
LC - Santa Lucia 18
MZ - Mozambico 18
NZ - Nuova Zelanda 18
PR - Porto Rico 18
YE - Yemen 18
BW - Botswana 17
DJ - Gibuti 17
Totale 5.321
Salva come PNG Salva come JPEG
Città #
Singapore 299
Hong Kong 262
Ashburn 149
Chicago 98
Los Angeles 94
Ho Chi Minh City 89
Hefei 80
Boardman 64
Bytom 53
Hanoi 46
Salt Lake City 43
Beijing 40
São Paulo 40
Vienna 37
Redondo Beach 34
Buffalo 33
New York 32
Kampala 26
Lusaka 26
Chandler 24
Tampa 24
Managua 23
Elk Grove Village 22
Nuremberg 22
Panama City 22
Luanda 21
Montevideo 21
Niamey 20
Baku 19
Cotonou 19
Dar es Salaam 19
Lima 19
Willemstad 19
Castries 18
Libreville 18
Abidjan 17
Amman 17
Bridgetown 17
Dakar 17
Helsinki 17
Kinshasa 17
Milan 17
Reykjavik 17
Tashkent 17
Yerevan 17
Addis Ababa 16
Conakry 16
Nassau 16
Riga 16
San José 16
Seoul 16
Bishkek 15
Cayenne 15
Djibouti 15
Dublin 15
Fairfield 15
Phnom Penh 15
Praia 15
Quito 15
Vientiane 15
Nairobi 14
Oslo 14
Rio de Janeiro 14
Ulan Bator 14
Andorra la Vella 13
Gaborone 13
Harare 13
Kuala Lumpur 13
Lilongwe 13
Nouakchott 13
Podgorica 13
San Juan 13
Seattle 13
Skopje 13
Auckland 12
Bamako 12
Dushanbe 12
Haiphong 12
Kigali 12
Ljubljana 12
Maputo 12
Minsk 12
Sanaa 12
Wilmington 12
Almaty 11
Athens 11
Biên Hòa 11
Brazzaville 11
Curitiba 11
Dallas 11
Havana 11
Houston 11
Jeddah 11
Kingstown 11
Lahore 11
Lancaster 11
Les Abymes 11
Luxembourg 11
Montreal 11
Munich 11
Totale 2.758
Salva come PNG Salva come JPEG
Nome #
The impact of survivorship bias in glioblastoma research 203
Clinical management of diffuse low-grade gliomas 164
Bevacizumab in recurrent glioblastoma: does dose matter? Our monocentric and comparative experience 149
Cervical intramedullary spinal cord metastasis from colon cancer: a systematic review and report of an illustrative case 146
Total neoadjuvant approach with FOLFOXIRI plus bevacizumab followed by chemoradiotherapy plus bevacizumab in locally advanced rectal cancer: the TRUST trial 137
Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial 126
Definition of the Prognostic Role of MGMT Promoter Methylation Value by Pyrosequencing in Newly Diagnosed IDH Wild-Type Glioblastoma Patients Treated with Radiochemotherapy: A Large Multicenter Study 125
New perspectives in liquid biopsy for glioma patients 112
Glioblastoma and Internal Carotid Artery Calcium Score: A Possible Novel Prognostic Partnership? 111
Early Versus Late Postoperative Radiotherapy in Patients With Prostate Cancer: Results of a Single-centre Retrospective Study 100
Decoding the puzzle: A multidisciplinary systematic review of adult brainstem glioma 98
Association of XRCC3 rs1799794 polymorphism with survival of glioblastoma multiforme patients treated with combined radio-chemotherapy 85
Correlation of Pre- and Post-radio-chemotherapy MRI Texture Features With Tumor Response in Rectal Cancer 82
Metabolic-imaging of human glioblastoma live tumors: A new precision-medicine approach to predict tumor treatment response early 81
Local therapy in glioma: An evolving paradigm from history to horizons (Review) 79
Dabrafenib treatment in a patient with BRAF V600E ganglioglioma: circulating exosome-derived cancer RNA supports treatment choice and clinical monitoring 79
Integrating stereotactic radiotherapy and systemic therapies 76
Surgical Management of Adult Brainstem Gliomas: A Systematic Review and Meta-Analysis 76
Old and New Systemic Immune-Inflammation Indexes Are Associated with Overall Survival of Glioblastoma Patients Treated with Radio-Chemotherapy 74
IDH1 mutation is detectable in plasma cell-free DNA and is associated with survival outcome in glioma patients 70
Nonrandomised controlled trial in recurrent glioblastoma patients: the promise of autologous tumour lysate-loaded dendritic cell vaccination 68
The Prognostic Impact of Gender, Therapeutic Strategies, Molecular Background, and Tumor-Infiltrating Lymphocytes in Glioblastoma: A Still Unsolved Jigsaw 66
Brain metastases from primary colorectal cancer: is radiosurgery an effective treatment approach? Results of a multicenter study of the radiation and clinical oncology Italian association (AIRO) 66
[18F]Fluorocholine PET/CT-guided stereotactic body radiotherapy in patients with recurrent oligometastatic prostate cancer 65
Akt1 rs2498801 Is Related to Survival in Head and Neck Squamous Cell Cancer Treated with Radiotherapy 64
The effectiveness of bevacizumab in radionecrosis after radiosurgery of a single brain metastasis 63
Learning and actioning general principles of cancer cell drug sensitivity 63
Brain Stem Glioma Recurrence: Exploring the Therapeutic Frontiers 63
Radiomics-Based Inter-Lesion Relation Network to Describe [18F]FMCH PET/CT Imaging Phenotypes in Prostate Cancer 62
Correction to: Association of XRCC3 rs1799794 polymorphism with survival of glioblastoma multiforme patients treated with combined radio-chemotherapy 61
Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO) 59
Electron FLASH radiotherapy in vivo studies. A systematic review 59
Cancer Stem Cells and Glioblastoma: Time for Innovative Biomarkers of Radio-Resistance? 59
Novel Advances in Treatment of Meningiomas: Prognostic and Therapeutic Implications 59
Innovative Approach to Isolate and Characterize Glioblastoma Circulating Tumor Cells and Correlation with Tumor Mutational Status 58
Exploring Extracellular Vesicle Surface Protein Markers Produced by Glioblastoma Tumors: A Characterization Study Using In Vitro 3D Patient-Derived Cultures 58
Non-melanoma skin cancer treated with high-dose-rate brachytherapy: A review of literature 58
Exploring Regorafenib Responsiveness and Uncovering Molecular Mechanisms in Recurrent Glioblastoma Tumors through Longitudinal In Vitro Sampling 56
Molecular portrait of a rare case of metastatic glioblastoma: somatic and germline mutations using whole-exome sequencing 56
Sustained Tumor Control With MAPK Inhibition in BRAF V600-Mutant Adult Glial and Glioneuronal Tumors 56
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 55
A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer 54
Definitive radiotherapy for recurrent vulvar carcinoma after primary surgery: a two-institutional Italian experience 52
Non-melanoma skin cancer treated with high-dose-rate brachytherapy and Valencia applicator in elderly patients: a retrospective case series 51
[F-18]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: preliminary results 51
A novel technique for combined treatment of high grade gliomas by means of surgery and peri-operative interstitial high dose rate brachytherapy (HDR-BCT192Ir) 50
Association of Glutathione S-Transferase P-1 (GSTP-1) rs1695 polymorphism with overall survival in glioblastoma patients treated with combined radio-chemotherapy 50
Policies for reirradiation of recurrent high-grade gliomas: a survey among Italian radiation oncologists 50
Management of de novo Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) and the role of Radiation Therapy: A Consensus by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 50
Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIRO 50
Association between RAD 51 rs1801320 and susceptibility to glioblastoma 49
Melanocortin Receptor-4 Gene Polymorphisms in Glioblastoma Patients Treated with Concomitant Radio-Chemotherapy 49
A multicenter real-world study of bevacizumab in heavily pretreated malignant gliomas: Clinical benefit is a plausible end point? 49
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study 49
Long-Term PSA Control with Repeated Stereotactic Body Radiotherapy in a Patient with Oligometastatic Castration-Resistant Prostate Cancer 48
Single-agent Bevacizumab in Recurrent Glioblastoma After Second-line Chemotherapy With Fotemustine: The Experience of the Italian Association of Neuro-Oncology 48
Stereotactic Body Radiotherapy in Patients with Lung Oligometastases from Colorectal Cancer 48
EP-1568 Long-term results of [18F] Fluorocholine PET/CT guided SBRT in patients with prostate cancer 47
Bevacizumab and fotemustine for recurrent glioblastoma: a phase II study of AINO (Italian Association of Neuro-Oncology) 47
Successful use of bevacizumab in an adult primary diffuse leptomeningeal glioneuronal tumor 47
Different timing to use bevacizumab in patients with recurrent glioblastoma: Early versus delayed administration 47
Single-Cell Molecular Characterization to Partition the Human Glioblastoma Tumor Microenvironment Genetic Background 47
The role of clinicopathologic and molecular prognostic factors in the post-mastectomy radiotherapy (PMRT): a retrospective analysis of 912 patients 46
Patient-reported outcomes in a phase II randomised study of regorafenib compared with lomustine in patients with relapsed glioblastoma (the REGOMA trial) 46
Epileptogenesis and oncogenesis: An antineoplastic role for antiepileptic drugs in brain tumours? 46
REGOMA: A randomized, multicenter, controlled open-label phase II clinical trial evaluating regorafenib (REG) activity in relapsed glioblastoma (GBM) patients (PTS) 45
Role of magnetic resonance imaging following postoperative radiotherapy in clinical decision-making of patients with high-grade glioma 45
Melanocortin Receptor-4 and Glioblastoma Cells: Effects of the Selective Antagonist ML00253764 Alone and in Combination with Temozolomide In Vitro and In Vivo 45
Synergistic antitumor activity of ZD6474, an inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling, with gemcitabine and ionizing radiation against pancreatic cancer 44
Detection of a second malignancy in prostate cancer patients by using [F-18] Choline PET/CT: a case series 44
Impact of recurrence pattern in patients undergoing a second surgery for recurrent glioblastoma 44
Single-fraction flattening filter-free volumetric modulated arc therapy for lung cancer: Dosimetric results and comparison with flattened beams technique 44
Adjuvant Radiotherapy in Patients With Pancreatic Adenocarcinoma. Is It Still Appealing in Clinical Trials? A Meta-analysis and Review of the Literature 44
Investigating molecular alterations to profile short- and long-term recurrence-free survival in patients with primary glioblastoma 43
EP-1648 Radio-chemotherapy with temozolomide in elderly patients with glioblastoma: our experience 43
O-(2-18F-fluoroethyl)-L-tyrosine (18F-FET) PET as a potential selection tool for second surgery in glioblastoma patients 42
[18F]FMCH PET/CT biomarkers and similarity analysis to refine the definition of oligometastatic prostate cancer 42
Clinical outcome of tailored adjuvant postoperative chemoradiotherapy in IB FIGO stage cervical cancer 41
Adjuvant chemoradiotherapy (gemcitabine-based) in pancreatic adenocarcinoma: the Pisa University experience 40
Surgical outcome and molecular pattern characterization of recurrent glioblastoma multiforme: A single-center retrospective series 40
Cyclin A and E2F1 overexpression correlate with reduced disease-free survival in node-negative breast cancer patients 40
Brain recurrences in patients with ovarian cancer: report of 12 cases and review of the literature 40
Basic and Translational Advances in Glioblastoma 39
Decipher the Glioblastoma Microenvironment: The First Milestone for New Groundbreaking Therapeutic Strategies 37
Association of plasma levetiracetam concentration, MGMT methylation and sex with survival of chemoradiotherapy-treated glioblastoma patients 37
Laser Capture Microdissection and RNA-Seq Analysis: High Sensitivity Approaches to Explain Histopathological Heterogeneity in Human Glioblastoma FFPE Archived Tissues 36
Tumor Microenvironment and Glioblastoma Cell Interplay as Promoters of Therapeutic Resistance 36
Sedoheptulose Kinase SHPK Expression in Glioblastoma: Emerging Role of the Nonoxidative Pentose Phosphate Pathway in Tumor Proliferation 36
Pattern of dysphagia after swallowing-sparing intensity-modulated radiotherapy (IMRT) of head and neck cancers: results of a mono-institutional prospective study 35
Impact of temporalis muscle thickness in elderly patients with newly diagnosed glioblastoma treated with radio or radio-chemotherapy 35
VEGFA SNP rs2010963 is associated with vascular toxicity in recurrent glioblastomas and longer response to bevacizumab 34
Radiation-induced nausea and vomiting in head and neck cancer: Is it something worth considering in the intensity modulated radiotherapy era? "A narrative review" 34
Stereotactic radiotherapy for bone oligometastases 34
Cancer astrocytes have a more conserved molecular status in long recurrence free survival (RFS) IDH1 wild-type glioblastoma patients: new emerging cancer players 34
Bevacizumab for the Treatment of Radiation-Induced Cerebral Necrosis: A Systematic Review of the Literature 34
Treatment of recurrent glioblastoma multiforme with fotemustine and brachytherapy 34
Vaginal toxicity after high-dose-rate endovaginal brachytherapy: 20 years of results 33
Stereotactic radiotherapy for oligometastases in the lymph nodes 33
Multiregional Sequencing of IDH-WT Glioblastoma Reveals High Genetic Heterogeneity and a Dynamic Evolutionary History 33
Set-up errors in head and neck cancer treated with IMRT technique assessed by cone-beam computed tomography: a feasible protocol 32
Totale 5.970
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.159
article - articoli 14.159
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.318
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202132 0 0 0 0 21 0 2 2 3 0 4 0
2021/202242 0 0 0 0 2 1 17 3 3 0 6 10
2022/202350 9 8 0 6 5 5 3 4 5 2 3 0
2023/202444 0 7 6 8 2 4 6 0 2 1 5 3
2024/20251.336 0 8 5 58 128 15 48 39 155 103 320 457
2025/20264.731 263 585 1.671 1.619 593 0 0 0 0 0 0 0
Totale 6.235